| Literature DB >> 27882272 |
Olga Crowley1, Laura Pugliese1, Stan Kachnowski2.
Abstract
OBJECTIVES: The Personal Health Management Study (PHMS) is an assessment of the effect of a voluntary employee-facing health initiative using a commercially-available wearable device implemented among 565 employees of Boehringer Ingelheim Pharmaceuticals, Inc. The results of the initiative on physical activity (measured as steps) and sleep is reported.Entities:
Keywords: digital health; employee wellness; physical activity; sleep; wearable technology
Year: 2016 PMID: 27882272 PMCID: PMC5106347 DOI: 10.7759/cureus.825
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
The sample’s demographic and clinical characteristics (N=510)
| Variable | N (%) | Range | Mean (SD) | |
| Age | 506 (99%) | 23-67 | 43.46 (9.20) | |
| Gender | Male | 232 (45%) | ||
| Female | 278 (55%) | |||
| BMI (Body Mass Index) | 503 (99%) | 18.11-51.37 | 27.66 (5.34) | |
| Chronic diseases | Blood clots | 8 (2%) | ||
| Heart disease | 7 (1%) | |||
| Heart murmur | 28 (5%) | |||
| Diabetes | 17 (3%) | |||
| Circulation problems | 5 (1%) | |||
| TIA or stroke | 3 (.6%) | |||
| Anemia or other blood disease | 26 (5%) | |||
| Depression | 0 (0%) | |||
| Cholesterol problems | 84 (16%) | |||
| Asthma | 43 (8%) | |||
| Thyroid disease | 23 (5%) | |||
| Peptic ulcer disease | 5 (1%) | |||
| Cancer | 12 (2%) | |||
| Colon polyp | 28 (5%) | |||
| Insomnia | 8 (2%) | |||
| Restless legs syndrome | 1 (.2%) | |||
| Sleep apnea | 13 (3%) | |||
| 510 (100%) | ||||
Figure 1Defining final sample size included in the data analysis
Significance of fixed effects tested in the model (Type 3): Steps
| Effect | Num DF | Den DF | F Value | Pr > F |
| Study month | 8 | 3106 | 7.48 | <.0001 |
| Baseline steps | 1 | 509 | 1605.83 | <.0001 |
| Baseline steps x study month | 8 | 3096 | 15.03 | <.0001 |
| Age | 1 | 490 | 2.89 | 0.0898 |
| Sex | 1 | 509 | 3.73 | 0.0541 |
| BMI | 1 | 487 | 0.24 | 0.6253 |
| Age x sex | 1 | 504 | 5.82 | 0.0162 |
| Age x BMI | 1 | 487 | 0.98 | 0.3236 |
Average steps per month
| Study Month | Mean | Standard Error | Δ* | p |
| Oct-13 | 7915.6 | 79.763 | - | - |
| Nov-13 | 7601.6 | 81.01 | -314 | 0.0004 |
| Dec-13 | 7140.3 | 83.5 | -461.4 | <.0001 |
| Jan-14 | 6787.5 | 84.9 | -352.74 | 0.0002 |
| Feb-14 | 7101.1 | 87.14 | 313.58 | 0.0012 |
| Mar-14 | 7179.7 | 89.88 | 78.59 | 0.4338 |
| Apr-14 | 7526.9 | 91.22 | 347.24 | 0.0008 |
| May-14 | 7897.8 | 93.47 | 370.9 | 0.0005 |
| Jun-14 | 7853.4 | 98.01 | -44.4 | 0.6912 |
| *Δ describes the difference between two consecutive months (significance at .006 level) | ||||
Average steps among young, middle-aged, and older men and women
| Age Groups | Sex | Mean | Std Dev | Δ |
| 23-38 years | Male (n=86) | 6671.59 | 2384.94 | 864.01 |
| Female (n=79) | 7535.6 | 2607.55 | ||
| 39-47 years | Male (n= 84) | 7693.07 | 3385.71 | 138.78 |
| Female (n= 86) | 7831.85 | 2836.55 | ||
| 48-67 years | Male (n= 59) | 7290.58 | 3663.77 | 219.3 |
| Female (n= 112) | 7509.88 | 3144.99 |
Significance of fixed effects tested in the model (Type 3): Sleep
| Effect | Num DF | Den DF | F Value | Pr > F |
| Study month | 8 | 2943 | 28.31 | <.0001 |
| Baseline steps | 1 | 503 | 484.59 | <.0001 |
| Baseline steps x study month | 8 | 2942 | 23.94 | <.0001 |
| Age | 1 | 443 | 0.15 | 0.6958 |
| Sex | 1 | 468 | 2.32 | 0.1285 |
| BMI | 1 | 440 | 0.02 | 0.8958 |
| Age x sex | 1 | 462 | 1.4 | 0.2369 |
| Age x BMI | 1 | 439 | 0.01 | 0.9123 |
Average hours of sleep per month
*Δ describes the difference between two consecutive months (significance at .006 level)
| Study Month | Mean | Standard Error | Δ* | p |
| Oct-13 | 7.16 | 0.04 | - | - |
| Nov-13 | 7.19 | 0.04 | 0.03 | 0.5368 |
| Dec-13 | 7.35 | 0.04 | 0.16 | 0.0006 |
| Jan-14 | 7.34 | 0.04 | -0.01 | 0.8689 |
| Feb-14 | 7.42 | 0.04 | 0.08 | 0.1234 |
| Mar-14 | 7.50 | 0.04 | 0.08 | 0.1515 |
| Apr-14 | 7.58 | 0.04 | 0.08 | 0.1377 |
| May-14 | 7.59 | 0.05 | 0.01 | 0.8607 |
| Jun-14 | 7.52 | 0.05 | -0.07 | 0.2521 |